MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 58 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $500,761 | -30.1% | 104,543 | +0.0% | 0.00% | – |
Q2 2023 | $715,941 | -11.0% | 104,517 | +1.2% | 0.00% | – |
Q1 2023 | $804,318 | +5.9% | 103,250 | 0.0% | 0.00% | – |
Q4 2022 | $759,364 | -6.8% | 103,250 | -0.1% | 0.00% | -100.0% |
Q3 2022 | $814,355 | -19.8% | 103,349 | -0.5% | 0.00% | 0.0% |
Q2 2022 | $1,015,673 | -19.1% | 103,905 | +12.7% | 0.00% | 0.0% |
Q1 2022 | $1,255,205 | – | 92,217 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |